| abstract |
This invention relates to thrombin inhibiting compounds having the Formula I n n X-Y-NH-(CH₂) r -G I n n n where X, Y, r and G have the values defined in the description, as well as pharmaceutical formulations containing those compounds and methods of their use as thrombin inhibitors, coagulation inhibitors, and thromboembolic disorder agents. |